inClinico
Clinical trial probability-of-success forecasting and protocol design analysis
- Tool type
- Clinical trial PoS forecasting platform
- Made for
- Pharma investors, BD teams, and trial designers
- Runs on
- Web-based platform
- Accessed through a login to the inClinico platform; no other runtime surfaces are stated.
What it does
inClinico forecasts the probability of success (PoS) of a single clinical trial using multimodal data about targets, diseases, clinical trial protocols, and the scientists involved in studies. Inputs include OMICs data, drug structures, preclinical data, publications, grants, and patents. It produces clinical trial outcome scores and customized reports showing PoS and the impact of individual features on predicted probabilities.
Teams use it to score custom trial designs, compare alternative protocols, and spot weak points in endpoints, eligibility criteria, randomization, blinding, and clinical sites. It also provides a database of historical and ongoing trials that can be sorted by PoS, plus industry-wide success rate analysis. A distinguishing feature is the quantified influence of each protocol feature and feature group, with simulation of alternative designs.
Named audiences are buy-side analysts at pharma-focused funds, business development executives at pharmaceutical companies, and clinical researchers and developers. Typical uses include due diligence, portfolio de-risking, and trial design enhancement. Access is arranged through a demo request or a call with the vendor.
What it can do
- Forecast probability of success for a single clinical trial using multimodal data
- Score custom trial designs and compare alternative protocols
- Search a database of historical and ongoing clinical trials sorted by probability of success
- Generate customized reports showing probabilities and feature impacts
- Provide actionable insights on changing protocol elements such as endpoints, eligibility, and sites
- Produce industry-wide success rate analysis and clinical trial sponsor reports
Before you choose
- Pricing, plan structure, and trial availability are not published; confirm cost with the vendor through a demo request.
- Predictions depend on the trial protocol and data inputs; prospective case studies are linked from the product page for validation details.
- The product page notes that people seeking clinical trial participation information should consult a healthcare provider, so the tool is aimed at professional analysis.
Listed under
Get started
The page offers Request a Demo and Schedule a Call options.
- Visit the inClinico page on pharma.ai and select Request a Demo.
- Provide contact details and product of interest through the request form.
- Schedule a call with the Insilico Medicine team using the listed contact email or Schedule a Call option.
Plans and prices
Pricing and billing terms must be confirmed with the vendor through a demo request.
We couldn’t find published prices for inClinico.
Sources for this overview
Product pages, documentation, and pricing checked 29 Oct 2026. Each source supports part of the overview; availability and prices can change.
- inClinico ↗pharma.ai
- Main | Insilico Medicine ↗insilico.com
Ratings and reviews
No ratings for inClinico yet.
What’s changed
Free accountSignals
Free accountData and security
Free accountCompare with similar tools
Free accountWhere this comes from
How we research- Company website
- pharma.ai: product, pricing and policy pages
- Web search
- Confirms the official site
- Social accounts
- Accounts the company links, and its posts on X
- Human review
- Checked by a person
- knowledge_base
- manual_review
Last checked 29 Oct 2026. Every field keeps its source and date; unknown means we couldn’t confirm it.